MedTrace Logo

Laparoscopic Sleeve Gastrectomy-Induced Decline in Plasma Asprosin and Its Association With Metabolic Recovery

NCT07008274 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2025-06-06

No results posted yet for this study

Summary

the present study aimed to systematically assess the changes in plasma asprosin levels at 3, 6, and 12 months after LSG, to explore the relationships between asprosin dynamics and key metabolic parameters, including body mass index (BMI), fasting glucose, insulin resistance assessed by the homeostasis model (HOMA-IR), and lipid profiles, and to compare asprosin concentrations between bariatric patients and healthy normal-weight controls.

Conditions

  • Obesity, Morbid

Interventions

PROCEDURE

surgery

laparoscopic sleeve gastrectomy

Sponsors & Collaborators

  • Northern Jiangsu People's Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07008274 on ClinicalTrials.gov